Response to letter to editor by Jolobe ‘Results have relevance for resolving discrepancies in the approach to population screening’
Ridderstråle, W., Saluveer, O., Johansson, M. C., Bergbrant, A., Jern, S., Hrafnkelsdóttir, T. J.
Published in Journal of internal medicine (01.06.2010)
Published in Journal of internal medicine (01.06.2010)
Get full text
Journal Article
Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease with a history of PCI: an economic evaluation of THEMIS-PCI using a Swedish healthcare perpective
Steg, P, Bhatt, D.L, James, S.K, Darlington, O, Hoskin, L, Simon, T, Fox, K, Leiter, L.A, Mehta, S, Harrington, R.A, Himmelmann, A, Ridderstrale, W, Andersson, M, Mellstrom, C, Mcewan, P
Published in European heart journal (01.11.2020)
Published in European heart journal (01.11.2020)
Get full text
Journal Article
Patients’ experiences of clinical trial participation involving a product remotely assessing study drug adherence
Henriksson, Catrin, Olsson, Anneli, Andersen, Kasper, Arefalk, Gabriel, Erlinge, David, Hofmann, Robin, Ridderstråle, Wilhelm, Rutgersson, Annika, Oldgren, Jonas, James, Stefan
Published in Contemporary clinical trials communications (01.08.2024)
Published in Contemporary clinical trials communications (01.08.2024)
Get full text
Journal Article
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
James, Stefan, Erlinge, David, Storey, Robert F, McGuire, Darren K, de Belder, Mark, Eriksson, Niclas, Andersen, Kasper, Austin, David, Arefalk, Gabriel, Carrick, David, Hofmann, Robin, Hoole, Stephen P, Jones, Daniel A, Lee, Kelvin, Tygesen, Hans, Johansson, Peter A, Langkilde, Anna Maria, Ridderstråle, Wilhelm, Parvaresh Rizi, Ehsan, Deanfield, John, Oldgren, Jonas
Published in NEJM evidence (01.02.2024)
Published in NEJM evidence (01.02.2024)
Get more information
Journal Article